NO177750C - Analogifremgangsmåte for fremstilling av et farmasöytisk tålbart pyridiniumsalt - Google Patents

Analogifremgangsmåte for fremstilling av et farmasöytisk tålbart pyridiniumsalt

Info

Publication number
NO177750C
NO177750C NO900116A NO900116A NO177750C NO 177750 C NO177750 C NO 177750C NO 900116 A NO900116 A NO 900116A NO 900116 A NO900116 A NO 900116A NO 177750 C NO177750 C NO 177750C
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutically acceptable
pyridinium salt
analogous process
analogous
Prior art date
Application number
NO900116A
Other languages
English (en)
Norwegian (no)
Other versions
NO900116L (no
NO177750B (no
NO900116D0 (no
Inventor
Shigeru Souda
Shuhei Miyazawa
Norihiro Ueda
Katsuya Tagami
Seiichiro Nomoto
Makoto Okita
Naoyuki Shimomura
Toshihiko Kaneko
Masatoshi Fujimoto
Manabu Murakami
Kiyoshi Oketani
Hideaki Fujisaki
Hisashi Shibata
Tsuneo Wakabayashi
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO900116D0 publication Critical patent/NO900116D0/no
Publication of NO900116L publication Critical patent/NO900116L/no
Priority to NO951979A priority Critical patent/NO951979D0/no
Publication of NO177750B publication Critical patent/NO177750B/no
Publication of NO177750C publication Critical patent/NO177750C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO900116A 1988-05-12 1990-01-10 Analogifremgangsmåte for fremstilling av et farmasöytisk tålbart pyridiniumsalt NO177750C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO951979A NO951979D0 (no) 1988-05-12 1995-05-19 Fremgangsmåte for fremstilling av et farmasöytisk tålbart pyridiniumsalt

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11549588 1988-05-12
JP11549488 1988-05-12
PCT/JP1989/000482 WO1989010927A1 (en) 1988-05-12 1989-05-11 Pyridinium salt and pharmacological composition containing the same

Publications (4)

Publication Number Publication Date
NO900116D0 NO900116D0 (no) 1990-01-10
NO900116L NO900116L (no) 1990-03-09
NO177750B NO177750B (no) 1995-08-07
NO177750C true NO177750C (no) 1995-11-15

Family

ID=26453988

Family Applications (1)

Application Number Title Priority Date Filing Date
NO900116A NO177750C (no) 1988-05-12 1990-01-10 Analogifremgangsmåte for fremstilling av et farmasöytisk tålbart pyridiniumsalt

Country Status (7)

Country Link
US (1) US5162317A (da)
EP (1) EP0374261A1 (da)
CA (1) CA1339369C (da)
DK (1) DK7690A (da)
FI (1) FI93121C (da)
NO (1) NO177750C (da)
WO (1) WO1989010927A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5505944A (en) * 1992-09-09 1996-04-09 Nippon Kayaku Kabushiki Kaisha Physiologically active substance NK175203, process for production thereof and pharmaceutical use thereof
JPH11227123A (ja) * 1998-02-19 1999-08-24 Dainippon Ink & Chem Inc 二軸延伸スチレン系樹脂積層シート及びその製造方法
WO2008047681A1 (en) * 2006-10-13 2008-04-24 Eisai R & D Management Co., Ltd. Benzimidazole compound having gastric acid secretion inhibitory activity
JP6322644B2 (ja) 2012-11-26 2018-05-09 エムキュア ファーマシューティカルズ リミテッド 酸分泌阻害薬としてのピリドン誘導体およびその製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8403179D0 (sv) * 1984-06-13 1984-06-13 Haessle Ab New compounds
SE8405588D0 (sv) * 1984-11-08 1984-11-08 Haessle Ab New compounds
DK337086A (da) * 1985-08-12 1987-02-13 Hoffmann La Roche Benzimidazolderivater
CA1276017C (en) * 1986-02-13 1990-11-06 Takeda Chemical Industries, Ltd. Sulfenamide derivatives and their production
FR2597478B1 (fr) * 1986-04-21 1988-12-16 Esteve Labor Dr Benzimidazoles et imidazopyridines sulfonamides, leur preparation et leur application en tant que medicaments.
EP0304624A3 (de) * 1987-07-29 1989-03-22 F. Hoffmann-La Roche Ag Benzimidazol-2-yl-pyridiniumverbindungen

Also Published As

Publication number Publication date
WO1989010927A1 (en) 1989-11-16
NO900116L (no) 1990-03-09
FI900098L (fi) 1990-01-09
FI93121C (fi) 1995-02-27
DK7690D0 (da) 1990-01-11
EP0374261A1 (en) 1990-06-27
CA1339369C (en) 1997-08-26
FI93121B (fi) 1994-11-15
NO177750B (no) 1995-08-07
FI900098A0 (fi) 1990-01-09
DK7690A (da) 1990-01-11
US5162317A (en) 1992-11-10
NO900116D0 (no) 1990-01-10

Similar Documents

Publication Publication Date Title
FI900886A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi
FI98196B (fi) Menetelmä mikroemulsion käsittävän farmaseuttisen formulaation valmistamiseksi
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
NO173914C (no) Fremgangsmaate ved fremstilling av et soetningsmiddel
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
NO882103L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
FI891538L (fi) Menetelmä farmaseuttisesti käyttökelpoisten fenolisubstituoitujen gem-difosfonaattijohdannaisten valmistamiseksi
FI890072A7 (fi) Menetelmä farmaseuttisesti käyttökelpoisten isokinoliinijohdannaisten valmistamiseksi
FI92696C (fi) Menetelmä terapeuttisesti käyttökelpoisten tiatsolidiinidionijohdannaisten valmistamiseksi
FI890283A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 25-hydroksi-vitamiinin D-johdannaisten valmistamiseksi
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
FI882590A7 (fi) Analogiamenetelmä lääkeaineena käytettävän pyridiinijohdannaisen valmistamiseksi
FI892948A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
NO301372B1 (no) Fremgangsmåte for fremstilling av et farmasöytisk tålbart salt av klavulansyre
NO177485C (no) Fremgangsmåte for fremstilling av et farmasöytisk inhalasjonspreparat
FI92825C (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
NO179396C (no) Fremgangsmåte ved fremstilling av en medikamentell administreringsform for drövtyggere
FI890186A7 (fi) Menetelmä 1-hydroksialkyyli-5-nitroimidatsolien valmistamiseksi
FI911420A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
FI890185A7 (fi) Menetelmä 1-alkyyli-5-nitroimidatsolien valmistamiseksi
FI92188C (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
NO176915C (no) Fremgangsmåte for fremstilling av et hirudin-derivat
FI893682L (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi
FI916036A0 (fi) Menetelmä valmistaa farmaseuttisesti käyttökelpoista spirofuraanijohdosta